Results 131 to 140 of about 73,286 (248)

Chronic and Recurrent Vulvovaginal Candidiasis.

open access: yesNippon Ishinkin Gakkai Zasshi, 1998
Approximately 15 % of non-pregnant women and 30 % of pregnant women yield positive cultures of Candida species in the vaginal specimens. A diagnosis of vulvovaginal candidiasis (VVC) should only be made when Candida spp. are isolated from the vulvovaginal area, together with the presence of signs and symptoms. In Japan several topical drugs for vaginal
openaire   +3 more sources

TREATMENT FOR RESISTANT VULVOVAGINAL CANDIDIASIS

open access: yes
Candida albicans and non-albicans series, the causative agents of vulvovaginal candidiasis, the most common infectious disease in gynecological practice, have a significant number of mechanisms to avoid the action of widely used groups of antifungal ...
Zyryanov S.K., Butranova O.I.
core   +1 more source

Molecular investigation of etiologic agents causing vulvovaginal candidiasis [PDF]

open access: yes, 2020
Background: Vulvovaginal candidiasis (VVC) is an ordinary infection caused by Candida species. Meanwhile, a shift towards non-albicans Candida (NAC) species has been detected in VVC patients.
Farahyar, S.   +5 more
core  

Overview of Vulvovaginal Candidiasis Diagnosis and Treatment

open access: yes, 2022
Vaginal yeast infections, also called yeast vaginitis or vulvovaginal candidiasis (VVC), are the second most common cause of vaginitis and account for more than ten million medical visits annually.
Rodriguez, Diana P
core   +1 more source

Physical aspects of photodinamic therapy application to chronic vulvovaginal candidiasis [PDF]

open access: yesГинекология, 2014
The aim of the presented research was investigation of induced by 5-ALA PPIX accumulation kinetics in mucosa, vagina and vulva chronic in women with vulvovaginal candidiasis after treatment of 5-ALA and the choice of optimal time mode of fluorescence ...
K O Aslanyan   +3 more
doaj  

Vulvovaginal candidiasis: diagnostic and therapeutic approaches used by Dutch general practitioners.

open access: yes, 2008
Contains fulltext : 69412.pdf (Publisher’s version ) (Closed access)OBJECTIVE: To establish how general practitioners (GPs) in the Netherlands diagnose and treat vaginal candidiasis.
Vinkers, M.T.   +7 more
core   +1 more source

Characteristics of the vaginal microbiota with a combination of bacterial vaginosis with the pathology of the vagina and cervix inflammatory genesis [PDF]

open access: yesГинекология, 2017
The article is devoted to investigation microbiocenosis of the genital tract reproductive age women with the combination of bacterial vaginosis together with pathology of vagina and cervix of the inflammatory genesis.
T Yu Pestrikova   +2 more
doaj  

Association of IL-18 Gene Polymorphism at Position -137G / C with Vaginal Candidiasis

open access: yesArmaghane Danesh Bimonthly Journal, 2015
Background & aim: Vulvovaginal Candidiasis (VVC) is a common disease affecting more than 75% of all women at least once in their lifetime. Various factors, including genetic and immunology factors, plays an important role in this disease.
M Solimanipour, S Naeimi
doaj  

Prevalence of vulvovaginal candidiasis among nonpregnant women attending a tertiary health care facility in Abuja, Nigeria

open access: yes, 2015
Anthony Uchenna Emeribe,1 Idris Abdullahi Nasir,2 Justus Onyia,2 Alinwachukwu Loveth Ifunanya31Department of Medical Laboratory Science, University of Calabar, Calabar, Cross River State, Nigeria; 2Department of Medical Microbiology, University of Abuja ...
Emeribe AU   +3 more
core  

Chitosan-based nanoparticles as a potential treatment for vulvovaginal candidiasis: a meta-analysis

open access: yes
Vulvovaginal candidiasis is a recurrent infection among women and chitosan nanoparticles would then be a suitable alternative treatment. As far as we are concerned, there are no previous systematic review.
Thaís Nogueira Barradas
core  

Home - About - Disclaimer - Privacy